CLINICAL_TRIALS
withdrawal
· 2025-09-10
Clinical Trial Update: Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room [Phase 2]
Summary
A Phase 2 clinical trial evaluating intranasal dexmedetomidine, fentanyl, and midazolam for safety and efficacy in the pediatric emergency department was withdr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nationwide Children's Hospital | Conditions: Acute Stress Disorder, Anxiety | Phase 2 | Status: WITHDRAWN